NASDAQ
Coya Therapeutics, Inc. (COYA) has a free cash flow growth of -516.46% as of Friday, May 29, 2026. This represents a 6750.18% decrease compared to its 12-month average of -7.54%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.